Loading the map…

Research and experimental development on biotechnology · Abingdon

Grey Wolf Therapeutics

Grey Wolf Therapeutics Limited

Losses 4 years runningActiveLatest figures: 2024Filed as a small companyAbridged accountsCompany only9 years on the register

Private limited company registered in Abingdon, classed under “Research and experimental development on biotechnology”.

Headline figures

FY to Dec 2024 · Company only

Turnover

For subscribers

Profit after tax

−£23m

Net assets

For subscribers

Cash

For subscribers

Employees

For subscribers

Retained reserves

For subscribers

What the numbers say

4 findings from the figures, in plain English

Written by rules from the figures on this page. Not a forecast or a credit opinion.

History

Pro
£202120222023*2024
Profit after tax−£23m
Turnover
Net assets
Cash
Employees
Retained reserves

Every figure for all 4 years

“—” means we did not find the figure in a source; it is never filled with an estimate. * Restated: the next year's accounts printed different figures for this year, and those later figures are shown.

Balance sheet and ratios

From the filed balance sheets · £

Balance sheet2021202220232024
Fixed assets
Current assets
of which debtors
of which cash
Creditors due within a year
Net current assets
Net assets
Ratios
Return on equityProfit after tax as a share of net assets
Current ratioCurrent assets for every £1 owed within a year
Cash ratioCash for every £1 owed within a year
Creditors to assetsEverything owed to creditors as a share of fixed plus current assets

7 balance-sheet lines and 4 ratios, every year

A ratio appears only for years where every line it needs was filed. Lines are as tagged in the accounts; nothing is added up or estimated.

Timeline

Checked 2026-10-27

  1. Shares
    Statement of capital following an allotment of shares on 21 October 2026 · GBP 3,063.8242 (and 19 more like it since 27 November 2020)
  2. Directors
    Termination of appointment of Edwin Moses as a director on 30 September 2026
  3. Accounts
    Amended accounts for a small company made up to 31 December 2025
  4. Accounts
    Accounts for a small company made up to 31 December 2025
  5. Shares
    Cancellation of shares. Statement of capital on 23 June 2026 · GBP 3,063.0773 (and 8 more like it since 26 October 2020)
  6. Shares
    Purchase of own shares (and 5 more like it since 26 October 2020)
  7. Filing
    Resolutions (and 12 more like it since 27 November 2020)
  8. Directors
    Appointment of Mr Edwin Moses as a director on 16 April 2026
  9. Filing
    Memorandum and Articles of Association (and 4 more like it since 27 November 2020)
  10. Directors
    Appointment of Allan Marchington as a director on 2 March 2026
  11. Directors
    Termination of appointment of Tracy Weightman as a director on 2 March 2026
  12. Filing
    Replacement filing of SH01 - 02/06/25 Statement of Capital gbp 2987.4578
  13. 27 earlier
    1. Directors
      Termination of appointment of Emma Johnson as a director on 10 December 2025
    2. Accounts
      Accounts for a small company made up to 31 December 2024
    3. Directors
      Appointment of Mr Paul John Grattan Stainer as a secretary on 1 May 2025
    4. Directors
      Termination of appointment of Samantha Ann Harris as a secretary on 1 March 2025
    5. Directors
      Appointment of Dr Ekaterina Smirnyagina as a director on 25 November 2024
    6. Directors
      Termination of appointment of Sally Marianne Dewhurst as a director on 25 November 2024
    7. Accounts
      Accounts for a small company made up to 31 December 2023
    8. Shares
      Second filing of a statement of capital following an allotment of shares on 22 May 2024 · GBP 2,393.4229 (and 1 more like it since 8 April 2021)
    9. Directors
      Appointment of Ms Tracy Weightman as a director on 15 May 2024
    10. Accounts
      Accounts for a small company made up to 31 December 2022
    11. Directors
      Appointment of Ms Marie-Claire Peakman as a director on 23 December 2022
    12. Directors
      Appointment of Miss Emma Johnson as a director on 23 December 2022
    13. Directors
      Appointment of Dr. Sally Marianne Dewhurst as a director on 23 December 2022
    14. Directors
      Appointment of Ms Rabab Nasrallah as a director on 23 December 2022
    15. Ownership
      Notification of a person with significant control statement
    16. Ownership
      Cessation of Biodiscovery 5 Fpci as a person with significant control on 12 February 2019
    17. Ownership
      Cessation of Canaan Xi L.P. as a person with significant control on 12 February 2019
    18. Directors
      Director's details changed for Mr Raphael Wisniewski on 1 January 2022
    19. Shares
      Change of share class name or designation (and 3 more like it since 25 October 2020)
    20. Shares
      Particulars of variation of rights attached to shares (and 2 more like it since 27 January 2021)
    21. Address
      Registered office address changed from Clarendon Business Centre 57 Woodstock Road Oxford OX2 6HJ England to 99 Park Drive Milton Abingdon OX14 4RY on 4 August 2022
    22. Directors
      Appointment of Ms Samantha Ann Harris as a secretary on 22 June 2022
    23. Accounts
      Accounts for a small company made up to 31 December 2021
    24. Ownership
      Cessation of Peter Joyce as a person with significant control on 29 March 2018
    25. Ownership
      Cessation of Thomas David Mccarthy as a person with significant control on 29 March 2018
    26. Directors
      Director's details changed for Mr Peter Joyce on 28 May 2021
    27. Accounts
      Accounts for a small company made up to 31 December 2020

From the Companies House filing history. Routine confirmation statements are left out, and a run of the same filing is shown once.

Questions people ask

›What does Grey Wolf Therapeutics do?

Private limited company registered in Abingdon, classed under “Research and experimental development on biotechnology”. In its own words: “Novel antigen modulation technology that controls T cells to guide the immune system”

›How much turnover does Grey Wolf Therapeutics make?

Answered in the full report

›Is Grey Wolf Therapeutics profitable?

No: it made a loss after tax of £23m in the year to 31 December 2024, its latest filed accounts.

›How many people work at Grey Wolf Therapeutics?

Answered in the full report

›Who runs and owns Grey Wolf Therapeutics?

Its directors are Paul John Grattan Stainer, Brenton Karl Ahrens, Thierry Hercend, Peter Joyce, Allan Patrick Marchington and 5 more. Its owners are shown to subscribers.

›Where is Grey Wolf Therapeutics based?

Its registered office is 99 Park Drive, Milton, Abingdon, OX14 4RY, in Abingdon.

›When was Grey Wolf Therapeutics founded?

Grey Wolf Therapeutics Limited was incorporated on 29 September 2017.

›Is Grey Wolf Therapeutics still trading?

The register lists Grey Wolf Therapeutics Limited as active.

More companies in Abingdon →